influenza surveillance paho region, 2005 2013 oliva.pdfinfluenza surveillance—paho region,...
TRANSCRIPT
![Page 1: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/1.jpg)
Influenza Surveillance—PAHO Region, 2005–2013
Otavio Oliva, MD, MPH
Rakhee Palekar, MD, MPH
January 29, 2013
Achievements and Future Challenges in the Surveillance of Respiratory Viruses
San Jose, Costa Rica
![Page 2: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/2.jpg)
2005–2008
• Threat of a pandemic
• PAHO-CDC Generic Protocol for Influenza Surveillance – Respiratory syndrome surveillance:
influenza-like illness (ILI) and severe acute respiratory infection (SARI)
– Unusual event surveillance (e.g. pneumonia in health care worker)
– Influenza and other respiratory virus laboratory diagnosis
![Page 3: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/3.jpg)
• Laboratory strengthening
– PAHO-CDC task force
• Standardize PCR equipment
• Standardize PCR methodology
– Increase number of National Influenza Centers (NICs) in the Region
2005–2008
![Page 4: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/4.jpg)
2005–2008
• National influenza preparedness plans (NIPPS)
– Multi-disciplinary teams
– Tabletop exercises
http://new.paho.org/hq/index.php?option=com_content&view=article&id=3394&Itemid=2495&to=2290
![Page 5: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/5.jpg)
2009
• Influenza (H1N1)pdm 09 virus emerged
• Challenges
– Limited laboratory capacity in some countries
– Limited data from severe cases
• Lessons learned
– Focus efforts on SARI surveillance
– Link laboratory and epidemiologic data
– Decentralize rRT-PCR capability
– Train laboratorians in data analysis
![Page 6: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/6.jpg)
2010–2012 SARI surveillance network
• 62 hospitals and laboratories
• Locations of hospitals: Barbados (1), Bolivia (8), Chile (6), Colombia (7), Costa Rica (7), Dominica (1), Ecuador (16), Honduras (3), Jamaica (6), Paraguay (5), St Vincents and the Grenadines (1), Suriname (1), and Trinidad and Tobago (1)
Own surveillance system
![Page 7: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/7.jpg)
• Data received and analyzed at Regional level
– Weekly reports summarizing epidemiology of influenza and other respiratory viruses
– Virologic database
2010–2012
http://ais.paho.org/phip/viz/ed_flu.asp
http://ais.paho.org/phip/viz/ed_flu.asp
![Page 8: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/8.jpg)
2010–2012
• Information system linking laboratory and epidemiologic data
![Page 9: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/9.jpg)
2010–2012
• Decentralization rRT-PCR
– Example Chile: all six sentinel sites with rRT-PCR capacity
![Page 10: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/10.jpg)
2010–2012
• Training materials
– Courses (available in English and Spanish)
• SARI training course http://cphp.sph.unc.edu/sari/precurso.html
• Laboratory data analysis course http://cphp.sph.unc.edu/paho/precurso.html
– Videos (available in Dutch, English, French, Portuguese, and Spanish)
• Nasopharyngeal and oropharyngeal sample collection http://new.paho.org/hq/index.php?option=com_content&view=article&id=7920&Itemid=39735&lang=en
• Using PPE http://new.paho.org/hq/index.php?option=com_content&view=article&id=7920&Itemid=39735&lang=en
![Page 11: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/11.jpg)
Unanswered Questions
![Page 12: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/12.jpg)
Unanswered Questions-Other Respiratory Viruses
• What explains the “other 40%”?
– Poor sensitivity of current methodologies for RSV, adenovirus, parainfluenza viruses?
– Viruses missing from current panel (e.g. bocavirus, human metapneumovirus, etc)
• Importance of RSV
– Burden high, not many resources being devoted to surveillance and vaccine efforts
![Page 13: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/13.jpg)
Unanswered Questions
![Page 14: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/14.jpg)
Unanswered Questions
Note: In United States, since 2001, in only half of the seasons did the B strain in the vaccine predominate in circulation
![Page 15: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/15.jpg)
Unanswered Questions-Influenza
• What surveillance strategy to use in Central America where no pattern exists
• Influenza B virus co-circulation
– Trivalent versus quadrivalent vaccines
• Burden of disease
• Novel influenza vaccines
![Page 16: Influenza Surveillance PAHO Region, 2005 2013 Oliva.pdfInfluenza Surveillance—PAHO Region, 2005–2013 Otavio Oliva, MD, MPH Rakhee Palekar, MD, MPH January 29, 2013 Achievements](https://reader033.vdocuments.pub/reader033/viewer/2022051914/600572a3ae860f7ad8690f91/html5/thumbnails/16.jpg)
Moving Forward
• Use systems established for influenza surveillance
– Generate influenza and RSV disease burden data
– Support influenza vaccine effectiveness studies
– Expand diagnostics for other respiratory viruses
• Strengthen influenza surveillance systems
– Develop plans for sustainability
– Maintain gains and consider limited expansion of surveillance